综合心理干预对慢性阻塞性肺疾病患者焦虑抑郁的应用研究被引量：11

Effect on the Depression and Anxiety of Chronic Obstructive Pulmonary Disease with Psychological Intervention

下载PDF

导出

摘要目的:探讨综合心理干预对慢性阻塞性肺疾病患者焦虑抑郁情绪的影响。方法:选取60例COPD患者,随机分为综合心理干预组和对照组,每组30例。两组给予常规抗炎、控制性氧疗、氨茶碱、祛痰及一般支持治疗;心理干预组在常规治疗基础上,由专业精神科医师团队进行专业心理干预。记录两组患者入院时及2周后心理量表及肺功能指标变化。结果:干预2周后综合心理干预组心理量表评分低于对照组(P<0.05),肺功能指标高于对照组(P<0.05)。结论:综合心理干预能更好地改善COPD患者焦虑抑郁情绪,更利于肺功能的改善。 Objective：To discuss the impacts of the psychological intervention on depression and anxiety of patients with chronic obstructive pulmonary disease（COPD）.Methods：Sixty patients with COPD were selected to randomly divide into the treatment group（30patients）and the control group（30patients）.Both groups were performed COPD standard treatment.The treatment group used psychological intervention at the same time.Both groups were tested with Hamilton anxiety scale（HAMA）and Hamilton depression scale（HAMD）on admission,in two weeks,respectively;they were recorded pulmonary function（FEV1%,FEV1/FVC%）.Results：There was markedly reduction in HAMD and HAMA scores within the two groups after treatment（P〈0.05）.The reduction of HAMD and HAMA scores before and after treatment was much more in the treatment group than in control group.After treatment,FEV1% and FEV1/FVC% of two groups were improved.The treatment group compared with control group improved significantly of pulmonary function.Conclusion：The psychological intervention can improve psychological states and pulmonary function.

作者白金凤薛培丽

机构地区四川省科学城医院

出处《医学理论与实践》 2015年第1期18-20,共3页 The Journal of Medical Theory and Practice

关键词慢性阻塞性肺疾病综合心理干预焦虑抑郁肺功能 Chronic obstructive pulmonary disease Psychological intervention Depression Anxiety Pulmonary function

分类号 R563 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献11

1Seemungal TA, Hurst JR, Wedzicha JA. Exacerbation rate, health status and mortality in COPD-a review of poten- tialintervenfions[J]. Int J Chron Obstruct Pulmon Dis, 2009,4:203-223.
2Huertas A, Palange P. COPD:a multifactorial systemic disease [J]. Ther Adv Respir Dis,2011,5(3).217-224.
3Yeo J, Karimova G, Bansal S. Co-morbidity in older patients with COPD-its impact on health serviceutilisation and quality of life, a community study [J]. Age Ageing, 2006,35 ( 1 ) 33- 37.
4Miravitlles M, Molina J, Quintano JA, et al. Factors associated with depression and severe depression in patients with COPD [J]. Respir Med,2014.
5Wiklund I, Berry P, Lu KX, et al. The Chinese translation of COPD assessment test (CAT)provides a valid and reliable measurement of COPD health status in Chinese COPD patients [J]. Am J Respir Crit Care Med,2010.
6Brenes GA. Anxiety and chronic obstructive pulmonary dis- ease: prevalence, impact, and treatment [J]. Psychosom Med, 2003,65 (6) : 963-970.
7Alcazar B,Garcia-Polo C, Herrejon A. Factors associated with hospital admissions for exacerbation of chronic obstructive pul- monary disease(J}. Arch Broneoneumol, 2012,48 (3) 70-76.
8Coventry PA, Gemmell I, Todd CJ. Psychosocial risk factors for hospital readmissions in COPD patients on early discharge services: a cohort study. BMC Pulm Med, 2011,4 ( 11 ) 49.
9Regvat J, Zmitek A, Vegnuti M,et at. Anxiety and depression during hospital treatment of exacerbation of chronic obstruc- tive pulmonary disease(J}. J Int Med Res, 2011,89(3) : 1028- 1038.
10Anisman H, Merali Z, Hayley S. Neurotransmitter, peptide and eytokine processes in relation to depressivedisorder: co- morbidity between depression and neurodegenerativedisorde- rs. Pro Neurobiol, 2008,85 (1) : 1-74.